Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-05-09

FDA Approved: VORICONAZOLE — Original Application (Meitheal Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved Meitheal Pharmaceuticals' original application for a generic voriconazole product, enabling marketing of a generic antifungal.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VORICONAZOLE (Voriconazole)

Snippet

ORIG AP for VORICONAZOLE (VORICONAZOLE)